Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/04/2003CN1110556C Isolated nucleic acid molecules for coding tumor rejection antigen precursor MAGE-3 and use thereof
06/04/2003CN1110554C Aspergillus oryzae 5-aminoevulinic acid synthase and nucleic acid encoding the same
06/04/2003CN1110503C Isolated, truncated nucleicacid molecules of codeed GAGE tumor exclusion antigen
06/04/2003CN1110369C Mesoscale sample preduction equipment and system for measuring and processing analytes
06/04/2003CN1110318C Antithrombosis medicine using inactive insuline as skeleton and containing arginine-glycine-aspartic acid sequence
06/03/2003US6573438 Seed comprising a nucleic acid construct with a expression cassette, promoter, alcohol dehydrogenase intron, DNA molecule encoding an insecticidal Cry protein and nopaline synthase terminator; given DNA sequences
06/03/2003US6573437 Acala variety using DNA which confers a phenotype (antibiotic/herbicide/glyphosate resistance); growing in a sucrose-free callus induction medium comprising glucose; transferring to a glucose-free, sucrose medium
06/03/2003US6573432 Regulation of anthocyanin pigment production
06/03/2003US6573431 Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses
06/03/2003US6573430 Cen gene and a method for delaying flowering
06/03/2003US6573429 Of given sequence; tobacco dehydogenase; use in producing disease resistance/insect resistance; can use in biosynthesis of ectoine, betaine, and fatty acid
06/03/2003US6573428 Chimeric gene comprising a transcription regulatory sequence linked to a heterologous nucleic acid sequence; filament of stamen; tissue-specific
06/03/2003US6573427 Nucleic acid molecule comprising transcriptional promoter, viral replicase, polypeptide encoding nucleic acid sequences, and promoter sequence; transcription; use to produce plants with novel phenotypes
06/03/2003US6573426 Isolated polynucleotide encoding a polypeptide having orotidine-5' monophosphate (OMP) decarboxylase activity
06/03/2003US6573425 Transformation with a transfer cassette flanked by recombination sites where the cassette comprises a nucleotide sequence of interest; recombinase
06/03/2003US6573374 Using carbocyanine group attached to base portion; less background interference
06/03/2003US6573373 High affinity, low molecular weight displacers for oligonucleotide purification
06/03/2003US6573371 Cell growth inhibiting and cell differentiation specific SYG972 gene, genomic DNA and promoter thereof
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573362 Of given amino acid sequence; binding inhibition; can use in reducing or influencing inflammations, improving wound healing, suppressing theimmune system for organ transplants, preventing metastasis of tumors and treating arteriosclerosis
06/03/2003US6573361 Antifungal proteins and methods for their use
06/03/2003US6573360 Human ABH
06/03/2003US6573338 High density, miniaturized arrays and methods of manufacturing same
06/03/2003US6573307 Process for making fluorinated polymer adsorbent particles
06/03/2003US6573244 Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins
06/03/2003US6573240 Controlling lepidopteran insect pests by contacting with effective amount of toxin comprising insecticidal fragment of specified amino acid sequence
06/03/2003US6573239 Compound comprising 15 to 26-residue peptide or peptide analogue which forms amphipathic alpha-helix in presence of lipids and exhibits specified lecithin:cholesterol acyltransferase activation activity
06/03/2003US6573101 High efficiency delivery of nucleic acid molecules into cells; permeabilizing target cells to facilitate nucleic acid uptake; use in gene transfer, gene therapy, disease treatment
06/03/2003US6573100 DNA vectors without a selection marker gene
06/03/2003US6573099 Genetic constructs for delaying or repressing the expression of a target gene
06/03/2003US6573098 Nucleic acid libraries
06/03/2003US6573097 Method of fertilizing an avian egg in the shell
06/03/2003US6573096 Continuous cell lines which produce monospecific antibodies that specifically bind an epitope of a human dipeptidyl peptidase IV and thereby inhibit angiogenesis; use in treatment of cancer
06/03/2003US6573095 Polynucleotides isolated from skin cells
06/03/2003US6573093 Temperature sensitive plasmids of P. haemolytica
06/03/2003US6573092 Method of preparing a eukaryotic viral vector
06/03/2003US6573091 Provide efficient and less harmful transmission of genetic vectors by retroviral particles; nucleic acid sequences; use to transmit genetic material for gene therapy, cell therapy, or other biotechnological applications
06/03/2003US6573090 Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
06/03/2003US6573089 Method for using and making a fiber array
06/03/2003US6573086 Transformed/transfected Chrysosporium lucknowense expressing/ secreting heterologous polypeptides; signal sequences; regula -tory sequences; mutants; Trichoderma reesei; use in making large amounts of protein/polypeptide in a low cost manner
06/03/2003US6573082 Streptococcus pneumoniae antigens and vaccines
06/03/2003US6573081 Method for growing circoviruses
06/03/2003US6573080 Buffalo green monkey kidney and a first type selected from human mucoepidermoid and lung carcinoma cells; detection of enterovirus
06/03/2003US6573079 Methods and interferon deficient substrates for the propagation of viruses
06/03/2003US6573078 Human immunodeficiency virus (HIV) protein fragments having antiviral activity; peptides derived from HIV transmembrane glycoprotein that inhibit HIV-induced cell-cell fusion; use for inhibition of enveloped viral infection
06/03/2003US6573077 Active site of human gamma glutamyl hydrolase
06/03/2003US6573076 Genes and encoded enzymes involved in cellulose biosynthesis by a bacterium; Acetobacter xylinum subsp. sucrofermentans; cellulase; cellulose synthase; use in transformation/genetic engineering of cellulose production in microorganisms
06/03/2003US6573075 Fumonisin detoxification compositions and methods
06/03/2003US6573073 Oligonucleotide regulatory sequence that increases promoter activity; vectors; gene therapy for cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR)
06/03/2003US6573072 Ribozymes having 2′-O substituted nucleotides in the flanking sequences
06/03/2003US6573071 Given amino acid sequence with a modification resulting in a different processing site; use in treating blood disorders
06/03/2003US6573070 DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
06/03/2003US6573067 Nucleic acid encoding sodium channels in dorsal root ganglia
06/03/2003US6573066 FtsH from Staphylococcus aureus
06/03/2003US6573062 Method for obtaining modulators of TNF receptor releasing enzyme
06/03/2003US6573059 DNA construct for the preparation of a fusion protein; green fluorescent protein
06/03/2003US6573054 Providing target polynucleotide, reference polynucleotides, oliognucleotide probes, subjecting to isothermal conditions for amplifying to form non- dissociative termolecular complexes; evaluation
06/03/2003US6573053 Digesting the genomic DNA to provide genomic fragments, ligating an adapter to each end, denaturing and re-annealing, recovering mismatch-free hybrids; use in comparing genomic DNA from two individuals who share a phenotype
06/03/2003US6573052 Method of determining a chemotherapeutic regimen based on ERCCI expression
06/03/2003US6573050 Reducing expression of tyrosinase related proteins (TYRP2) in cancer cells by contacting the cells with an antisense oligonucleotide targeting mRNA of the protein
06/03/2003US6573048 Degradable nucleic acid probes and nucleic acid detection methods
06/03/2003US6573046 To transform a target DNA sequence using nuclease resistant oligonucleotide
06/03/2003US6573045 Reporter molecule and RNA target molecule, both carrying a fluorescent or chromogenic group, placed in close proximity to each other; addition of test compound inhibits their binding and increases fluorescence; drug screening
06/03/2003US6572881 Delivery of polynucleotides to cells; polylactam
06/03/2003US6572864 Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
06/03/2003US6572863 Genome is modified to disable VPR and TAT to prevent their expression; stop codons to prevent translation
06/03/2003US6572857 Psoriasis; humanized sub clone of IOR T1A produced by the hybridoma deposited with ECACC, CAMR under accession number 96112640, having heavy and light chains with humanized variable regions.
06/03/2003US6572853 Recombinant human beta interferon with enhanced solubility
06/03/2003US6572852 Genetic engineering
06/03/2003CA2240454C Method for transforming indica rice
06/03/2003CA2220418C Oligonucleotide sizing using cleavable primers
06/03/2003CA2217633C Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides
06/03/2003CA2145523C Polypeptides involved in streptogramineae biosynthesis; nucleotide sequences coding said polypeptides and their use
06/03/2003CA2138997C Vaccine composition containing adjuvants
06/03/2003CA2101639C Herpes simplex virus-1 deletion variants and vaccines thereof
06/03/2003CA2094275C Methods and compositions for the treatment of cell proliferation disorders
06/03/2003CA2050535C Bacteriophage resistant recombinant bacteria
05/2003
05/30/2003WO2003044532A1 Method for detecting analyte(s) using magnetic colloidal particles
05/30/2003WO2003044232A1 Method of detection of prostate cancer
05/30/2003WO2003044231A1 Method and kit for proximity probing with multivalent proximity probes
05/30/2003WO2003044230A1 Method and kit for detection of novel pathogen inhibitors
05/30/2003WO2003044227A1 Method of screening gene expressed at desired part
05/30/2003WO2003044225A2 Profiling of the immune gene repertoire
05/30/2003WO2003044217A2 Automated sample preparation methods and devices
05/30/2003WO2003044216A2 Multiplex oligonucleotide addition and target amplification
05/30/2003WO2003044214A2 Methods and compositions in checkpoint signaling
05/30/2003WO2003044213A2 Cell and tissue arrays and microarrays and methods of use
05/30/2003WO2003044207A2 Method for the preparation of nucleic acids
05/30/2003WO2003044206A2 Process for the preparation of an enantiomerically enriched a-amino acid
05/30/2003WO2003044205A1 Method for production of asymmetric carotenoids
05/30/2003WO2003044203A2 Homologous recombination vector, preparations and uses
05/30/2003WO2003044202A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof
05/30/2003WO2003044201A1 Genetically modified plants with enhanced resistance to fungal diseases and a method of production thereof
05/30/2003WO2003044200A1 Nucleotide sequence coding for an enzyme having acetolactase synthase activity, plant cell and plant containing same, and crop weeding method
05/30/2003WO2003044199A1 Recombinant bacillus phytases and uses thereof
05/30/2003WO2003044198A1 Artificial antibody library with super-repertory
05/30/2003WO2003044197A1 Huntington’s disease gene transcriptional factors
05/30/2003WO2003044196A1 Postsynaptic proteins
05/30/2003WO2003044195A1 Method of amplifying target single-stranded nucleic acid fragment
05/30/2003WO2003044194A1 Selection and evolution of nucleic acids and polypeptides